CHANGES IN EXTERNAL RESPIRATORY FUNCTION IN PATIENTS WITH BRONCHIAL ASTHMA

CHANGES IN EXTERNAL RESPIRATORY FUNCTION IN PATIENTS WITH BRONCHIAL ASTHMA

Authors

  • Roziqulov Azamat Qurbonmurod o‘g‘li PhD, Associate Professor, Termez Branch of Tashkent State Medical University
  • Sayidova Shahnoza Shahriddin qizi 2nd-year Master’s student, Termez Branch of Tashkent State Medical University

Keywords:

bronchial asthma, external respiratory function, pulmonary function, spirometry, airway obstruction, FEV₁, FVC, peak expiratory flow, bronchial inflammation, bronchodilator responsiveness.

Abstract

This article examines changes in external respiratory function in patients with bronchial asthma, focusing on the physiological mechanisms and clinical significance of airway obstruction. Particular attention is given to the assessment of pulmonary function parameters, including forced expiratory volume in one second (FEV₁), forced vital capacity (FVC), the FEV₁/FVC ratio, and peak expiratory flow (PEF). The study analyzes the effects of chronic airway inflammation, bronchoconstriction, mucus hypersecretion, and airway remodeling on respiratory function. Based on a review of scientific literature, the article highlights the importance of spirometry and bronchodilator responsiveness testing in identifying variable airflow limitation and evaluating respiratory impairment. The findings emphasize that regular monitoring of pulmonary function contributes to early diagnosis, assessment of disease control, and optimization of individualized treatment strategies for patients with bronchial asthma.

References

World Health Organization. (2024). Asthma. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/asthma

2. Global Initiative for Asthma. (2024). Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. https://ginasthma.org/

3. Hough, K. P., Curtiss, M. L., Blain, T. J., Liu, R. M., Trevor, J., Deshane, J. S., & Thannickal, V. J. (2020). Airway remodeling in asthma. Frontiers in Medicine, 7, Article 191. https://doi.org/10.3389/fmed.2020.00191

4. Graham, B. L., Steenbruggen, I., Miller, M. R., et al. (2019). Standardization of spirometry 2019 update: An official American Thoracic Society and European Respiratory Society technical statement. American Journal of Respiratory and Critical Care Medicine, 200(8), e70–e88. https://doi.org/10.1164/rccm.201908-1590ST

5. Stanojevic, S., Kaminsky, D. A., Miller, M. R., et al. (2022). ERS/ATS technical standard on interpretive strategies for routine lung function tests. European Respiratory Journal, 60(1), Article 2101499. https://doi.org/10.1183/13993003.01499-2021

6. Fehrenbach, H., Wagner, C., & Wegmann, M. (2017). Airway remodeling in asthma: What really matters. Cell and Tissue Research, 367, 551–569. https://doi.org/10.1007/s00441-016-2566-8

7. Papi, A., Brightling, C., Pedersen, S. E., & Reddel, H. K. (2018). Asthma. The Lancet, 391(10122), 783–800. https://doi.org/10.1016/S0140-6736(17)33311-1

8. Miller, M. R., Hankinson, J., Brusasco, V., et al. (2005). Standardisation of spirometry. European Respiratory Journal, 26(2), 319–338. https://doi.org/10.1183/09031936.05.00034805

9. Reddel, H. K., Bacharier, L. B., Bateman, E. D., et al. (2022). Global Initiative for Asthma Strategy 2021: Executive summary and rationale for key changes. European Respiratory Journal, 59(1), Article 2102730. https://doi.org/10.1183/13993003.02730-2021

10. Wenzel, S. E. (2012). Asthma phenotypes: The evolution from clinical to molecular approaches. Nature Medicine, 18(5), 716–725. https://doi.org/10.1038/nm.2678

11. Global Initiative for Asthma. (2025). Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. https://ginasthma.org/

12. Pellegrino, R., Viegi, G., Brusasco, V., et al. (2005). Interpretative strategies for lung function tests. European Respiratory Journal, 26(5), 948–968. https://doi.org/10.1183/09031936.05.00035205

13. Holgate, S. T. (2012). Innate and adaptive immune responses in asthma. Nature Medicine, 18(5), 673–683. https://doi.org/10.1038/nm.2731

14. Fahy, J. V. (2015). Type 2 inflammation in asthma—Present in most, absent in many. Nature Reviews Immunology, 15(1), 57–65. https://doi.org/10.1038/nri3786

15. Haldar, P., Pavord, I. D., Shaw, D. E., et al. (2008). Cluster analysis and clinical asthma phenotypes. American Journal of Respiratory and Critical Care Medicine, 178(3), 218–224. https://doi.org/10.1164/rccm.200711-1754OC

Downloads

Published

2026-11-16
Loading...